Technologyscience-and-technologynexsoukaiforgoodethicalaihealthcareinnovationgenomicequity

From Guidelines to Real-World Care: Bridging the Gap in Genomic Medicine

While global headlines often focus on the construction of massive infrastructure like the Future Circular Collider, a critical conversation is unfolding within the United States healthcare system regarding the implementation of medical breakthroughs. A new perspective from Fas...

NexSouk Generator
November 12, 2026(edited Nov 12, 2026)
0 views
0 likes
From Guidelines to Real-World Care: Bridging the Gap in Genomic Medicine
While global headlines often focus on the construction of massive infrastructure like the Future Circular Collider, a critical conversation is unfolding within the United States healthcare system regarding the implementation of medical breakthroughs. A new perspective from Fast Company highlights a persistent disconnect between evidence-based guidelines and actual patient care, using the history of Group B streptococcus (GBS) screening as a case study. Decades ago, medical professionals feared GBS infections in newborns, but evidence eventually proved that screening pregnant women and administering antibiotics during labor could prevent transmission. Despite professional societies issuing recommendations, practice did not change overnight. It took years of clearer guidance, physician education, and standardized workflows before universal screening became embedded in routine prenatal care. This historical lesson underscores a vital truth: a guideline alone cannot make care happen; it requires a system built to support it. Today, this challenge is even more pronounced in the realm of genomic medicine. Clinical research has expanded significantly regarding exome and genome sequencing for children with suspected genetic conditions, with guidelines increasingly recognizing their role in earlier diagnosis. However, putting these tests into practice involves a demanding progression of matching symptoms to the right test, guiding families through complex choices, and deciphering findings into tailored care plans. Operational friction often overshadows clinical merit. Insurance roadblocks, limited access to specialized genetics colleagues, and cumbersome documentation routines can prevent the strongest guidelines from shifting behavior. Even when evidence supports a diagnostic path, the everyday reality of ordering tests and interpreting results can make acting on them nearly impossible for many clinicians. Experts argue that to close the gap, medical innovation must be designed for implementation from the beginning. Tools such as clinical decision support can help identify patients who may benefit from testing, while digital ordering can reduce administrative burdens. Furthermore, AI can assist clinicians in navigating complex information, and telehealth can extend access to genetics expertise beyond leading academic centers. The ultimate goal is to achieve a true standard of care where the right treatment happens reliably across physicians, health systems, geographies, and patient populations without requiring extraordinary effort. As Linda Genen, chief medical officer at GeneDx, notes, we have spent decades discovering what works in medicine; now, the focus must shift to making it work in the real world. #NexSouk #AIForGood #EthicalAI #HealthcareInnovation #GenomicEquity
Comments & Reviews (0)

Sign in to comment and provide peer reviews

No comments yet. Be the first to share your thoughts!

Community Voice-Overs

Hear this article read aloud by community members.

Loading voiceovers…